- Home
- ITOS vs CIA Comparison
ITOS vs CIA Comparison
Compare ITOS & CIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITOS
- CIA
- Stock Information
- Founded
- ITOS 2011
- CIA 1969
- Country
- ITOS United States
- CIA United States
- Employees
- ITOS N/A
- CIA N/A
- Industry
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- CIA Life Insurance
- Sector
- ITOS Health Care
- CIA Finance
- Exchange
- ITOS Nasdaq
- CIA Nasdaq
- Market Cap
- ITOS 272.5M
- CIA 230.6M
- IPO Year
- ITOS 2020
- CIA N/A
- Fundamental
- Price
- ITOS $7.48
- CIA $5.07
- Analyst Decision
- ITOS Strong Buy
- CIA
- Analyst Count
- ITOS 3
- CIA 0
- Target Price
- ITOS $21.33
- CIA N/A
- AVG Volume (30 Days)
- ITOS 268.0K
- CIA 101.9K
- Earning Date
- ITOS 03-05-2025
- CIA 03-13-2025
- Dividend Yield
- ITOS N/A
- CIA N/A
- EPS Growth
- ITOS N/A
- CIA N/A
- EPS
- ITOS N/A
- CIA 0.43
- Revenue
- ITOS $35,000,000.00
- CIA $248,376,000.00
- Revenue This Year
- ITOS $271.18
- CIA N/A
- Revenue Next Year
- ITOS N/A
- CIA $3.85
- P/E Ratio
- ITOS N/A
- CIA $11.17
- Revenue Growth
- ITOS N/A
- CIA 3.02
- 52 Week Low
- ITOS $7.09
- CIA $1.78
- 52 Week High
- ITOS $18.75
- CIA $5.95
- Technical
- Relative Strength Index (RSI)
- ITOS 43.24
- CIA 60.35
- Support Level
- ITOS $7.30
- CIA $4.69
- Resistance Level
- ITOS $7.91
- CIA $4.95
- Average True Range (ATR)
- ITOS 0.32
- CIA 0.26
- MACD
- ITOS -0.02
- CIA 0.04
- Stochastic Oscillator
- ITOS 17.82
- CIA 67.86
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.
About CIA Citizens Inc. ($1.00 Par)
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. the Company derives its revenues principally from life insurance premiums earned for insurance coverages provided to insureds in our two operating segments and net investment income. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment.